AI-generated summary
The authors report a cost-effectiveness analysis alongside a randomized, double-blind trial comparing photobiomodulation therapy plus a preventive oral care program with the care program alone in patients receiving radiotherapy. They found the combined approach to be more cost-effective for preventing severe oral mucositis, worsening of oral health-related quality of life, and radiotherapy interruptions. The authors describe the therapy as promising, especially for avoiding interruptions in cancer treatment.
- Who or what was studied
- Patients receiving radiotherapy for cancer at a Brazilian cancer hospital who were randomized to photobiomodulation plus a preventive oral care program (n = 25) or the oral care program alone (n = 23).
- Limits stated in the abstract
- The abstract does not report the wavelength used, and the analysis is based on a single hospital setting in Brazil with a modest sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis, Trial registration, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.